#Sweden #Barcelona #Health Risks #Irritable Bowel Syndrome #Antibiotic Use

Early Antibiotic Use Linked to Irritable Bowel Syndrome in Young Adults

Recent research presented at UEG Week 2026 points to a compelling association between early antibiotic use and an increased risk of developing Irritable Bowel Syndrome (IBS) in young adulthood. The study analyzed data from 2,853 participants from the Swedish birth cohort BAMSE, focusing on antibiotic prescriptions recorded in the Swedish Prescribed Drug Register from 2005, when participants were ages 9 to 11, through to evaluations for IBS at age 24.

Key Findings

The findings reveal that by the age of 24, approximately 10% of participants reported having IBS. Notably, those diagnosed with IBS had a strikingly higher frequency of antibiotic prescriptions; 87.8% of IBS patients had received antibiotics compared to 80.2% of those without the condition. After adjusting for variables such as sex and socio-economic status, the results indicated that individuals prescribed antibiotics were 1.5 times more likely to develop IBS than their counterparts who had not been prescribed antibiotics (95% CI 1.0–2.2).

Moreover, the risk of developing IBS increased with the number of antibiotic prescriptions. Participants who received one or two prescriptions had a 1.3 times higher likelihood of IBS (95% CI 0.9–2.0). This risk further escalated to 1.6 times (95% CI 1.0–2.4) for those with three to five prescriptions and an alarming 1.7 times (95% CI 1.1–2.6) for individuals with six or more prescriptions.

Specific Antibiotic Classes Impact

Upon deeper investigation into various classes of antibiotics, tetracyclines and cephalosporins emerged as having a significant association with an elevated risk of IBS. The use of tetracyclines was linked to a 1.4 times greater chance (95% CI 1.1–1.8) of developing IBS, while prescription of three or more cycles of cephalosporins made individuals 6.0 times more likely (95% CI 1.9–18.8) to develop the syndrome.

Understanding the Underlying Mechanism

Although the study did not delve into the underlying causes of the connection between antibiotic exposure and IBS, one possible explanation is the alteration of the gut microbiome. Dr. Jessica Sjölund, the lead author, explained, "Previous studies have indicated that antibiotics can disrupt the intestinal microbiome. Given that disturbances in this microbiome are believed to play a role in IBS, this could be one of the underlying mechanisms accounting for the observed association."

Practical Implications

When reflecting on the practical implications of these findings, Dr. Sjölund emphasized the critical need to balance the indispensable role of antibiotics with careful prescribing practices. "Antibiotics remain essential for treating bacterial infections, and our results should not deter their use when necessary. Instead, they underscore the potential long-term effects of repeated exposure and reinforce the case for avoiding unnecessary antibiotic prescriptions."

This study serves as a crucial reminder of the implications associated with antibiotic use from an early age and encourages a broader conversation about responsible prescribing practices within the medical community and the importance of monitoring long-term health outcomes in population studies.